Monday - September 15, 2025
Ascletis Pharma, Gannex Pharma Face ITC Exclusion, Cease & Desist Orders Over Trade Secret Misappropriation
June 06, 2025
WASHINGTON, June 6 (TNSFR) -- The International Trade Commission has issued a final determination finding a violation of Section 337 of the Tariff Act of 1930 as amended in an investigation concerning certain selective thyroid hormone receptor-beta agonists. This ruling specifically targets companies for misappropriation of trade secrets, leading to the issuance of a limited exclusion order and cease and desist orders.

The Commission's investigation, initiated on February 9, 20 . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products